PETALING JAYA: Ucrest Bhd
has been granted its first patent in Taiwan for its flagship product, an artificial intelligence (AI)-powered digital health platform, iMedic.
In a filing with Bursa Malaysia, the company said the patent signifies a major achievement in its intellectual property journey and reinforces its leadership in the global digital healthcare industry.
The platform, consisting of intelligent connectivity and secure data infrastructure, enables iMedic to deliver highly personalised healthcare, continuous monitoring, and predictive analytics for preventive care and chronic disease management.
The patent will protect UCrest’s AI-powered diagnostics, personalised health analytics and remote patient management.
